GLP1 and GIP receptor activator, a next-generation injectable medication that combines the effects of two hormones to regulate blood sugar and support significant weight loss. Prescribed for type 2 diabetes and obesity management, it helps reduce appetite, improve insulin sensitivity, and promote sustained metabolic health.

Dose depends on the prescriber 2.25mg,4.5mg, 6.75mg and so on up to 15mg

Inject 2.25mg SQ Weekly, Inject 4.5mg SQ Weekly, Inject 6.75mg SQ Weekly, Inject 9mg SQ Weekly

Pricing varies by dosage and is confirmed after your provider consultation.